Show simple item record

dc.contributor.authorShi, Y.
dc.contributor.authorDuan, Y.
dc.contributor.authorJi, Y.
dc.contributor.authorWang, Z.
dc.contributor.authorWu, Y.
dc.contributor.authorGunosewoyo, Hendra
dc.contributor.authorXie, X.
dc.contributor.authorChen, J.
dc.contributor.authorYang, F.
dc.contributor.authorLi, J.
dc.contributor.authorTang, J.
dc.contributor.authorXie, X.
dc.contributor.authorYu, L.
dc.date.accessioned2017-09-27T10:20:33Z
dc.date.available2017-09-27T10:20:33Z
dc.date.created2017-09-27T09:48:06Z
dc.date.issued2017
dc.identifier.citationShi, Y. and Duan, Y. and Ji, Y. and Wang, Z. and Wu, Y. and Gunosewoyo, H. and Xie, X. et al. 2017. Amidoalkylindoles as Potent and Selective Cannabinoid Type 2 Receptor Agonists with in Vivo Efficacy in a Mouse Model of Multiple Sclerosis. Journal of Medicinal Chemistry. 60 (16): pp. 7067-7083.
dc.identifier.urihttp://hdl.handle.net/20.500.11937/56683
dc.identifier.doi10.1021/acs.jmedchem.7b00724
dc.description.abstract

Selective CB 2 agonists represent an attractive therapeutic strategy for the treatment of a variety of diseases without psychiatric side effects mediated by the CB 1 receptor. We carried out a rational optimization of a black market designer drug SDB-001 that led to the identification of potent and selective CB 2 agonists. A 7-methoxy or 7-methylthio substitution at the 3-amidoalkylindoles resulted in potent CB 2 antagonists (27 or 28, IC 50 = 16-28 nM). Replacement of the amidoalkyls from 3-position to the 2-position of the indole ring dramatically increased the agonist selectivity on the CB 2 over CB 1 receptor. Particularly, compound 57 displayed a potent agonist activity on the CB 2 receptor (EC 50 = 114-142 nM) without observable agonist or antagonist activity on the CB 1 receptor. Furthermore, 57 significantly alleviated the clinical symptoms and protected the murine central nervous system from immune damage in an experimental autoimmune encephalomyelitis (EAE) mouse model of multiple sclerosis.

dc.publisherAmerican Chemical Society
dc.titleAmidoalkylindoles as Potent and Selective Cannabinoid Type 2 Receptor Agonists with in Vivo Efficacy in a Mouse Model of Multiple Sclerosis
dc.typeJournal Article
dcterms.source.volume60
dcterms.source.number16
dcterms.source.startPage7067
dcterms.source.endPage7083
dcterms.source.issn0022-2623
dcterms.source.titleJournal of Medicinal Chemistry
curtin.departmentSchool of Pharmacy
curtin.accessStatusFulltext not available


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record